Wells Fargo’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$268K Sell
23,582
-22,141
-48% -$240K ﹤0.01% 4521
2025
Q4
$587K Buy
45,723
+16,258
+55% +$201K ﹤0.01% 4370
2025
Q3
$329K Buy
29,465
+4,616
+19% +$44.5K ﹤0.01% 4619
2025
Q2
$247K Buy
24,849
+621
+3% +$6.08K ﹤0.01% 4649
2025
Q1
$228K Buy
24,228
+513
+2% +$5.39K ﹤0.01% 4614
2024
Q4
$217K Buy
23,715
+6,200
+35% +$45.6K ﹤0.01% 4750
2024
Q3
$136K Buy
17,515
+754
+4% +$5.45K ﹤0.01% 4832
2024
Q2
$101K Buy
16,761
+3,136
+23% +$19.4K ﹤0.01% 4933
2024
Q1
$80K Buy
13,625
+1,740
+15% +$10.3K ﹤0.01% 5026
2023
Q4
$93.2K Buy
11,885
+2,473
+26% +$17.2K ﹤0.01% 4949
2023
Q3
$68.8K Sell
9,412
-7,173
-43% -$59.7K ﹤0.01% 5000
2023
Q2
$173K Buy
16,585
+6,676
+67% +$64.3K ﹤0.01% 4676
2023
Q1
$102K Buy
9,909
+7,337
+285% +$93.9K ﹤0.01% 4782
2022
Q4
$35.4K Sell
2,572
-1,300
-34% -$18.1K ﹤0.01% 5015
2022
Q3
$79K Sell
3,872
-237
-6% -$5.2K ﹤0.01% 4731
2022
Q2
$79K Sell
4,109
-54,305
-93% -$1.11M ﹤0.01% 4776
2022
Q1
$1.26M Sell
58,414
-10,238
-15% -$232K ﹤0.01% 3687
2021
Q4
$1.9M Sell
68,652
-438,306
-86% -$12.1M ﹤0.01% 3551
2021
Q3
$13.2M Sell
506,958
-727,445
-59% -$19.5M ﹤0.01% 1981
2021
Q2
$33.5M Sell
1,234,403
-16,335
-1% -$399K 0.01% 1324
2021
Q1
$29.3M Buy
1,250,738
+8,817
+0.7% +$178K 0.01% 1379
2020
Q4
$19M Buy
1,241,921
+12,809
+1% +$163K ﹤0.01% 1597
2020
Q3
$14.8M Buy
1,229,112
+22,670
+2% +$215K ﹤0.01% 1606
2020
Q2
$12.3M Buy
1,206,442
+78,476
+7% +$809K ﹤0.01% 1695
2020
Q1
$11.8M Buy
1,127,966
+109,616
+11% +$1.38M ﹤0.01% 1562
2019
Q4
$16.3M Sell
1,018,350
-120,468
-11% -$1.84M ﹤0.01% 1599
2019
Q3
$21M Sell
1,138,818
-23,916
-2% -$468K 0.01% 1408
2019
Q2
$22.9M Sell
1,162,734
-19,116
-2% -$389K 0.01% 1397
2019
Q1
$27M Buy
1,181,850
+41,425
+4% +$899K 0.01% 1254
2018
Q4
$23M Buy
1,140,425
+36,779
+3% +$761K 0.01% 1292
2018
Q3
$24M Buy
1,103,646
+21,218
+2% +$471K 0.01% 1392
2018
Q2
$24.1M Sell
1,082,428
-132,500
-11% -$2.71M 0.01% 1366
2018
Q1
$21M Buy
1,214,928
+76,767
+7% +$1.28M 0.01% 1424
2017
Q4
$18.9M Buy
1,138,161
+112,928
+11% +$1.93M 0.01% 1485
2017
Q3
$17.5M Buy
1,025,233
+9,639
+0.9% +$162K 0.01% 1510
2017
Q2
$16.5M Buy
1,015,594
+470,522
+86% +$7.44M 0.01% 1517
2017
Q1
$9.46M Sell
545,072
-12,358
-2% -$207K ﹤0.01% 1926
2016
Q4
$9.4M Sell
557,430
-94,089
-14% -$1.57M ﹤0.01% 1896
2016
Q3
$11.4M Buy
651,519
+25,296
+4% +$410K ﹤0.01% 1678
2016
Q2
$9M Buy
626,223
+49,264
+9% +$616K ﹤0.01% 1919
2016
Q1
$7.09M Buy
576,959
+43,469
+8% +$480K ﹤0.01% 2053
2015
Q4
$6.48M Buy
533,490
+174,613
+49% +$2.15M ﹤0.01% 2161
2015
Q3
$4.73M Sell
358,877
-12,521
-3% -$189K ﹤0.01% 2374
2015
Q2
$6.09M Buy
371,398
+23,812
+7% +$395K ﹤0.01% 2269
2015
Q1
$6.18M Buy
347,586
+10,664
+3% +$198K ﹤0.01% 2230
2014
Q4
$6.4M Buy
336,922
+43,895
+15% +$744K ﹤0.01% 2152
2014
Q3
$4.02M Sell
293,027
-33,774
-10% -$482K ﹤0.01% 2479
2014
Q2
$5.34M Buy
326,801
+74,104
+29% +$1.07M ﹤0.01% 2283
2014
Q1
$3.98M Buy
252,697
+247,549
+4,809% +$4.03M ﹤0.01% 2481
2013
Q4
$88K Buy
5,148
+745
+17% +$11.5K ﹤0.01% 4562
2013
Q3
$58K Sell
4,403
-4,351
-50% -$51.3K ﹤0.01% 4640
2013
Q2
$99K Buy
+8,754
New +$93.1K ﹤0.01% 4396

Other funds holding ANGO

Wells Fargo's ANGO Position: Q1 2026 in Review

Wells Fargo reduced its AngioDynamics (ANGO) stake by 48% in Q1 2026, selling an estimated $240K and leaving 23,582 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #4521.

Wells Fargo first reported a position in ANGO in Q2 2013 and has held it in 52 quarters since. The position peaked at $33.5M in Q2 2021. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Wells Fargo held 23,582 shares of AngioDynamics worth $268K as of Q1 2026.
  • Wells Fargo sold 22,141 AngioDynamics shares in Q1 2026, an estimated $240K.
  • AngioDynamics made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4521 holding.
  • Wells Fargo first reported a position in AngioDynamics in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's AngioDynamics position peaked at $33.5M in Q2 2021.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.